Filing Details

Accession Number:
0000899243-22-001651
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-11 21:11:44
Reporting Period:
2022-01-11
Accepted Time:
2022-01-11 21:11:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1827087 Vigil Neuroscience Inc. VIGL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451612 Bruce Booth Vigil Neuroscience, Inc.
1 Broadway, 7Th Floor, Suite 07-300
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-11 2,831,520 $0.00 4,273,896 No 4 C Indirect By Atlas Venture Fund XII, L.P.
Common Stock Acquisiton 2022-01-11 1,027,978 $0.00 1,027,978 No 4 C Indirect By Atlas Venture Opportunity Fund I, L.P.
Common Stock Acquisiton 2022-01-11 535,000 $14.00 4,808,896 No 4 P Indirect By Atlas Venture Fund XII, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Atlas Venture Fund XII, L.P.
No 4 C Indirect By Atlas Venture Opportunity Fund I, L.P.
No 4 P Indirect By Atlas Venture Fund XII, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2022-01-11 7,852,374 $0.00 2,831,520 $0.00
Common Stock Series B Preferred Stock Disposition 2022-01-11 2,850,789 $0.00 1,027,978 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
  2. These shares are held directly by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII"). The general partner of Atlas Venture Fund XII is Atlas Venture Associates XII, L.P. ("AVA XII LP"). Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XII, except to the extent of his pecuniary interest therein, if any.
  3. The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any.
  4. On January 11, 2022, Atlas Venture Fund XII purchased 535,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.